FDA Approves Bayer’s New Drug for Seco
Bayer announced approval of new drug Sunharbo (Asundexian) by USFDA to reduce the risk of
Warning letters, 483s, Recalls, Import Alerts, Audit observations
Bayer announced approval of new drug Sunharbo (Asundexian) by USFDA to reduce the risk of
The Government of India has issued draft notification G.S.R. 955(E) dated 28 October 2026, proposing
The Government of India has issued a draft notification, G.S.R. 956(E), proposing a significant amendment
On 27 October, CDSCO issued a circular directing State Drug Controllers to ensure that vendors
Baxter International Inc, was issued an FDA Warning Letter following cGMP violations observed during an
The Ministry of Health and Family Welfare, Government of India has issued the Medical Devices
The USFDA issued a Form 483 to Strides Pharma Sciences Ltd., Bangalore facility (FEI 3004554612)
Aurobindo’s Eugia Pharma Specialities Limited (FEI 3011960448), located at Shameerpet, India, has been classified OAI
The U.S. FDA has issued a Warning Letter to Simtra BioPharma Solutions following cGMP deviations
The USFDA has issued a Warning Letter to the Indian drug manufacturing facility of Patcos